vimarsana.com
Home
Live Updates
Evaluating Work Productivity, Efficacy and Safety of Tildrakizumab in Patients With Plaque Psoriasis : comparemela.com
Evaluating Work Productivity, Efficacy and Safety of Tildrakizumab in Patients With Plaque Psoriasis
Two posters presented at the 2023 Fall Clinical Dermatology Conference assessed phase 4 study findings on tildrakizumab in patients with moderate to severe plaque psoriasis.
Related Keywords
,
Clinical Dermatology Conference ,
Work Productivity ,
Activity Impairment Questionnaire ,
Psoriasis ,
Tildrakizumab ,
Safety And Efficacy ,
Psoriasis Treatments ,
Plaque Psoriasis ,
comparemela.com © 2020. All Rights Reserved.